These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 23944273)

  • 1. Endogenous fibrinolytic potential in tissue-plasminogen activator-modified thromboelastography analysis is significantly decreased in dogs suffering from diseases predisposing to thrombosis.
    Spodsberg EH; Wiinberg B; Jessen LR; Marschner CB; Kristensen AT
    Vet Clin Pathol; 2013 Sep; 42(3):281-90. PubMed ID: 23944273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
    Godier A; Parmar K; Manandhar K; Hunt BJ
    J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of coagulation and fibrinolysis in Irish Wolfhounds and age-matched control dogs using tissue plasminogen activator-augmented viscoelastic testing.
    Davis S; Fletcher DJ; Newman A; Brooks MB
    J Vet Emerg Crit Care (San Antonio); 2024; 34(3):222-230. PubMed ID: 38775137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.
    Flight SM; Masci PP; Lavin MF; Gaffney PJ
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of inflammation and hematocrit on clot strength in canine thromboelastographic hypercoagulability.
    Marschner CB; Wiinberg B; Tarnow I; Markussen B; Kühnel L; Bochsen L; Kristensen AT
    J Vet Emerg Crit Care (San Antonio); 2018 Jan; 28(1):20-30. PubMed ID: 29171709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboelastography results on citrated whole blood from clinically healthy cats depend on modes of activation.
    Marschner CB; Bjørnvad CR; Kristensen AT; Wiinberg B
    Acta Vet Scand; 2010 Jun; 52(1):38. PubMed ID: 20529334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of native and citrated whole blood samples for rapid thromboelastography in Beagles.
    Wang H; Nam A; Song K; Youn HY; Seo KW
    J Vet Emerg Crit Care (San Antonio); 2020 Jan; 30(1):54-59. PubMed ID: 31845529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of primary hyperfibrinolysis and in vitro investigation of the inhibitory effects of tranexamic acid in a group of dogs with sarcomas - A pilot study.
    Langhorn R; Poulsen MK; Heidemann PL; Bochsen L; Ritz C; Kristensen AT; Nielsen LN
    Res Vet Sci; 2021 May; 136():472-477. PubMed ID: 33838456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography.
    Panigada M; Zacchetti L; L'Acqua C; Cressoni M; Anzoletti MB; Bader R; Protti A; Consonni D; D'Angelo A; Gattinoni L
    PLoS One; 2015; 10(8):e0136463. PubMed ID: 26308340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.
    Moore HB; Moore EE; Chapman MP; Gonzalez E; Slaughter AL; Morton AP; D'Alessandro A; Hansen KC; Sauaia A; Banerjee A; Silliman CC
    J Thromb Haemost; 2015 Oct; 13(10):1878-87. PubMed ID: 26256459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation status, fibrinolysis, and platelet dynamics in dogs with chronic inflammatory enteropathy.
    Wennogle SA; Olver CS; Shropshire SB
    J Vet Intern Med; 2021 Mar; 35(2):892-901. PubMed ID: 33665845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs.
    Wiinberg B; Jensen AL; Rozanski E; Johansson PI; Kjelgaard-Hansen M; Tranholm M; Kristensen AT
    Vet J; 2009 Jan; 179(1):121-9. PubMed ID: 17920966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of platelet function and fibrinolysis in 20 dogs with trauma.
    Birkbeck R; Chan DL; McBride D; Cortellini S
    J Vet Emerg Crit Care (San Antonio); 2024; 34(1):40-48. PubMed ID: 38055340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
    Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
    Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator.
    Moore HB; Moore EE; Huebner BR; Dzieciatkowska M; Stettler GR; Nunns GR; Lawson PJ; Ghasabyan A; Chandler J; Banerjee A; Silliman C; Sauaia A; Hansen KC
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1014-1022. PubMed ID: 29190254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use.
    Bauer N; Eralp O; Moritz A
    J Vet Diagn Invest; 2009 Sep; 21(5):641-8. PubMed ID: 19737759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography.
    Johansson PI; Bochsen L; Andersen S; Viuff D
    Transfusion; 2008 Nov; 48(11):2377-83. PubMed ID: 18657078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine-proteases as plasminogen activators in terms of fibrinolysis.
    Flemmig M; Melzig MF
    J Pharm Pharmacol; 2012 Aug; 64(8):1025-39. PubMed ID: 22775207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.